Status:
WITHDRAWN
TRANSFORM Heart Failure with Reduced Ejection Fraction
Lead Sponsor:
Massachusetts General Hospital
Collaborating Sponsors:
American College of Cardiology
Conditions:
Heart Failure, Systolic
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The goal of the TRANSFORM-HFrEF trial will be to study the current guideline-directed medical therapy (GDMT) landscape for HFrEF and determine effective methods and models of increasing adherence to G...
Detailed Description
Heart Failure (HF) is the cardiovascular epidemic of the 21st century, affecting millions of patients worldwide. It is believed that HF is the only cardiovascular diagnosis rising in incidence among e...
Eligibility Criteria
Inclusion
- Age ≥18 years
- Clinical diagnosis of HF with EF ≤40% documented within 1 year of enrollment
- Receiving ≥1 oral medication for HF at study enrollment (including diuretics, ACEI/ARB/ARNI, beta-blockers, MRA, SGLT2i or thiazide diuretics.
Exclusion
- Current or anticipated participation in a clinical trial
- Currently receiving comfort care or enrolled in hospice
- Life expectancy \<1 year
- History of or plan for heart transplantation or left ventricular assist device
- Current or planned hemodialysis
Key Trial Info
Start Date :
October 22 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2024
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04872959
Start Date
October 22 2021
End Date
May 1 2024
Last Update
November 20 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.